Pacific Biosciences of California, Inc. (PACB) vs Sight Sciences, Inc. (SGHT)
Pacific Biosciences of California, Inc. and Sight Sciences, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. and Sight Sciences, Inc. are of similar size ($484.9M and $478.2M). Sight Sciences, Inc. grew revenue faster over the last twelve months: 9.27% against 2.02%. Sight Sciences, Inc. has the higher net margin (−35.7% vs −82.5%) and the lower return on invested capital (−125.2% vs −22.2%). Across the 17 metrics below, Sight Sciences, Inc. leads on 12 and Pacific Biosciences of California, Inc. on 5.
Valuation
Profitability
| Metric | PACB | SGHT | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.38% | 87.96% | 56.01% |
| Operating margin | (83.53%) | (33.43%) | (15.03%) |
| Net margin | (82.49%) | (35.69%) | (20.40%) |
| Free cash flow margin | (50.53%) | (27.98%) | (7.24%) |
| Return on equity | (929.31%) | (48.42%) | (15.32%) |
| Return on assets | (16.66%) | (26.24%) | (19.72%) |
| Return on invested capital | (22.22%) | (125.18%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack